Director of Global Tax
PCI Pharma Services | |
United States, Pennsylvania, Philadelphia | |
3001 Red Lion Road (Show on map) | |
Sep 01, 2026 | |
|
Life changing therapies. Global impact. Bridge to thousands of biopharma companies and their patients. We are PCI. Our investment is in People who make an impact, drive progress and create a better tomorrow. Our strategy includes building teams across our global network to pioneer and shape the future of PCI. Company Overview We are a leading global Contract Development & Manufacturing Organization (CDMO) serving the pharmaceutical and biotech industries, with approximately $2B in annual revenue and operations across North America, Europe, and Asia. Backed by private equity and operating in a high-growth environment, the company is scaling globally, expanding manufacturing capabilities, and enhancing financial infrastructure in preparation for future strategic transactions. Position Summary The Director of Tax is responsible for managing the Company's global tax strategy, compliance, and provision process. This role is highly strategic, partnering with Finance, Treasury, Legal and regional business teams to support global structuring, M&A activity, and operational scaling, while ensuring compliance in a dynamic regulatory landscape. Key Responsibilities Evaluate and build the future optimal tax organization (most likely in a continued co-sourcing model setup) that can successfully operate in a Public Company setting Ability to proactively lead the necessary steps to transform the tax function from Private Equity to a Public Company Tax department Lead global tax strategy, focusing on tax optimization to lower the effective tax rate and improve cash flow Manage third party advisors preparing global income tax compliance including US and international filings Lead quarterly and annual global tax provision leveraging third party advisors, ASC 740 tax disclosures and effective tax rate forecasting Establish, document and manage transfer pricing policies for global services, intellectual property and shared resources Support senior leadership, advising on tax implications of international expansion, M&A, legal entity structuring, and cross-border transactions Support tax due diligence and integration strategy for M&A transactions Assess process, technology requirements to ensure appropriate internal control procedures and drive SOX readiness Manage the relationship with external auditors for all global Tax related audit and external reporting requirements Partner cross-functionally with Finance, Accounting, Legal, Treasury, and Operations. Qualifications Bachelor's degree in Accounting, Finance, or related field (Master's preferred). CPA required; MST or JD preferred. 12+ years of progressive tax experience including multinational environment. Experience in life sciences, manufacturing, or CDMO environment preferred. Experience in private equity-backed or pre-IPO environment is a plus. Technical Skills Strong knowledge of ASC 740 and U.S. international tax rules (GILTI, FDII, Subpart F). Experience with transfer pricing frameworks and global indirect tax exposure. Familiarity with ERP systems (JDE preferred) and tax provision tools. Leadership Competencies Strategic thinker with strong business acumen. Ability to operate in high-growth, fast-paced environments. Strong leadership and team-building skills. Executive presence and communication abilities. Join us and be part of building the bridge between life changing therapies and patients. Let's talk future Equal Employment Opportunity (EEO) Statement: At PCI, Equity and Inclusion are at the core of our company's purpose: Together, delivering life-changing therapies. We are committed to cultivating an inclusive workplace by holding ourselves accountable to the highest standards of understanding, fairness, respect, and equal opportunity - at every level. We envision a PCI community where everyone can belong and grow, and we strive to bring this vision to reality by continuously and intentionally assessing our people practices, policies and programs, marketing approach, and workplace culture. | |
Sep 01, 2026